Efrat Dotan

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Ghassan K. Abou‐Alfa, Vaibhav Sahai, Antoine Hollebecque et al. · The Lancet Oncology · 2020 · 1.5K citations · Full text

Gastrointestinal Oncology, Medicine, Hepatobiliary Tumor +11

Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1.2K citations · Full text

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary et al. · Journal of the National Comprehensive Cancer Network · 2017 · 1K citations

Surgical Oncology, Oncologic Imaging, Gastroenterology +18

Cancer-Related Fatigue, Version 2.2015

Ann M. Berger, Kathi Mooney, Amy Alvarez-Perez et al. · Journal of the National Comprehensive Cancer Network · 2015 · 896 citations · Full text

Palliative Care, Fatigue Management, Medicine +10

Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019

Margaret A. Tempero, Mokenge P. Malafa, E. Gabriela Chiorean et al. · Journal of the National Comprehensive Cancer Network · 2019 · 365 citations

Surgical Oncology, Pancreatic Cancer, Guidelines Insights +15